Abortion pills would be safe even over-the-counter, a new study says : NPR

Key Points:

• A new study published in JAMA Internal Medicine suggests that patients can accurately self-assess their eligibility for medication abortion using an over-the-counter (OTC) style packaging prototype called "MiMi," indicating potential for expanded access to abortion pills without clinician supervision.
• Despite decades of research supporting the safety and efficacy of abortion medications mifepristone and misoprostol, current political and legal barriers—including bans in over a dozen states and ongoing court cases—limit access and prevent OTC availability.
• Experts highlight that OTC medication abortion could be a logical extension of current telemedicine practices, where patients receive the medication remotely and self-administer at home, but political stigma and regulatory challenges complicate FDA approval.
• Recent political actions by some Republican lawmakers, including efforts to revoke full FDA approval of mifepristone and impose stricter regulations, have intensified scrutiny and hindered progress toward OTC abortion medication.
• Drawing parallels to the multi-year process of approving OTC birth control pills, researchers emphasize the need for continued evidence-building and public interest demonstration to eventually overcome political obstacles and achieve OTC status for abortion medication.